Esmolol Hydrochloride

盐酸艾司洛尔

Report date: 2022/08/24 10:53:01
NME

Base Information

Drug NameEsmolol Hydrochloride
Drug Alias NameEsmololum4-苯丙酸甲酯的盐酸盐艾司诺尔艾斯洛尔艾司咯尔 +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonists
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsDiabetes MellitusHypertension +[15] 
Global Approved IndicationsHypertensionTachycardia, SinusTachycardia, Supraventricular +[6] 
Approved Indications in ChinaHypertensionTachycardia, SinusAtrial Flutter +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date1986/12/31
Country/TerritoryUnited StatesEgyptFrance +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovalead Pharma Private LtdLondon Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph'sBaxter Hlthcare +[9] 
Inactive CompaniesIntermountain Health Care IncJohns Hopkins University
Active IndicationsDrug-Related Side Effects and Adverse ReactionsDiabetes MellitusHypertension +[13] 
Inactive IndicationsBrain Injuries, TraumaticPrimary Dysautonomias

Other Information

ATC CodeC07AB09
Related LinksWikipediaDrugBankKEGG